A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults
Recruiting
Phase 1
Interventional Study
Healthy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 26 (estimated)
- Sponsor
- Pfizer · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this clinical study is to learn about how different injector pens affect:
* how the study medicine (called Genotropin) is delivered into the body and
* how the study medicine is taken up into the blood in healthy adults.
The study is seeking participants who are:
* Aged 18 to 60 years old
* Male or female who are healthy as determined by medical assessment
* Body-mass index (BMI)…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Healthy Participants
* BMI 16 to 32 kg/m2
* body weight more than 45kg
Exclusion Criteria:
* Ongoing or past history of significant medical conditions
* Use of prescription or non prescription medications within 14 days of first study dose
* Previous exposure to growth hormo…
Contacts